← Back to Search

Tetragraph (TM) NMT Monitor for Surgery

N/A
Waitlist Available
Research Sponsored by Joseph D. Tobias
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the surgery
Awards & highlights

Study Summary

This trial will compare a new nerve stimulator to the standard one to see if it's better for pediatric patients during surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
EMG changes

Trial Design

1Treatment groups
Experimental Treatment
Group I: TetragraphExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tetragraph (TM) NMT Monitor
2021
N/A
~100

Find a Location

Who is running the clinical trial?

Joseph D. TobiasLead Sponsor
20 Previous Clinical Trials
3,704 Total Patients Enrolled
4 Trials studying Surgery
382 Patients Enrolled for Surgery

Media Library

Tetragraph (TM) NMT Monitor Clinical Trial Eligibility Overview. Trial Name: NCT04475250 — N/A
Surgery Research Study Groups: Tetragraph
Surgery Clinical Trial 2023: Tetragraph (TM) NMT Monitor Highlights & Side Effects. Trial Name: NCT04475250 — N/A
Tetragraph (TM) NMT Monitor 2023 Treatment Timeline for Medical Study. Trial Name: NCT04475250 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~24 spots leftby Apr 2025